Study of Gojihwadi kwatha in the management of Bronchitis

Pharmaceutico-Analytical and Clinical evaluation of modified dosage forms of Gojihwadi kwatha in the management of kaphajakasa w.s.r.to Bronchitis

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/09/028118

Enrollment

Registered

2020-09-28

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J209- Acute bronchitis, unspecified

Interventions

Intervention1: Gojihwadi syrup: Dose 10 ml bd Route of administration Oral Intervention2: Gojihwadi granules: Dose 5g bd Route of administration Oral Intervention3: Gojihwadikwath churna: Dose 20g b

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients of either sex with Age between 18 years to 60 years 2. Patients with symptoms described in the context of KaphajaKasa 3. Duration of illness not more than 15 days.

Exclusion criteria

Exclusion criteria: 1. Patients of either sex with Age before 18 years and after 60 years 2. Patients without symptoms described in the context of KaphajaKasa 3. Duration of illness not more than 15 days.

Design outcomes

Primary

Measure	Time frame
. To clinically evaluate the effect of classical and modified forms of Gojihwadi kwatha in the management of Kaphaja kasaTimepoint: 15 days	—

Secondary

Measure	Time frame
To prepare classical and modified dosage forms of Gojihwadi kwatha 2.To analyze the prepared samples following standard parameters. Timepoint: 15 days	—

Countries

India

Contacts

Public ContactDr Deepak Kumar Sharma

National Institute of Ayurveda Jaipur

raj147sharma@gmail.com9414401151

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026